期刊文献+

CXCL5/CXCR2 axis in tumor microenvironment as potential diagnostic biomarker and therapeutic target 被引量:21

原文传递
导出
摘要 The components of the tumor microenvironment(TME)in solid tumors,especially chemokines,are currently attracting much attention from scientists.C-X-C motif chemokine ligand 5(CXCL5)is one of the important chemokines in TME.Over-expression of CXCL5 is closely related to the survival time,recurrence and metasta-sis of cancer patients.In TME,CXCL5 binds to its receptors,such as C-X-C motif chemokine receptor 2(CXCR2),to participate in the recruitment of immune cells and promote angiogenesis,tumor growth,and metastasis.The CXCL5/CXCR2 axis can act as a bridge between tumor cells and host cells in TME.Blocking the trans-mission of CXCL5/CXCR2 signals can increase the sensitivity and effectiveness of immunotherapy and slow down tumor progression.CXCL5 and CXCR2 are also regarded as biomarkers for predicting prognosis and molecular targets for customiz-ing the treatment.In this review,we summarized the current literature regarding the biological functions and clinical significance of CXCL5/CXCR2 axis in TME.The possibility to use CXCL5 and CXCR2 as potential prognostic biomarkers and thera-peutic targets in cancer is also discussed.
出处 《Cancer Communications》 SCIE 2020年第2期69-80,共12页 癌症通讯(英文)
基金 the Project of Jiangsu Provincial Key medical talents in Jiangsu Province,Grant/Award Number:ZDRCA2016034。
  • 相关文献

参考文献2

二级参考文献16

  • 1Strieter RM, Polverini PJ, Kunkel SL, et al. The functional roleof the ELR motif in CXC chemokine-mediated angiogenesis. J BiolChem, 1995,270:27348-27357.
  • 2Park JY, Park KH, Bang S, et al. CXCL5 overexpression isassociated with late stage gastric cancer. J Cancer Res Clin Oncol,2007,133:835-840.
  • 3Begley LA, Kasina S, Mehra R, et al. CXCL5 promotes prostatecancer progression. Neoplasia, 2008,10 :244-254.
  • 4Kawamura M, Toiyama Y, Tanaka K, et al. CXCL5, a promoterof cell proliferation, migration and invasion, is a novel serumprognostic marker in patients with colorectal cancer[ J/OL] . Eur JCancer, 2011 [2012-04-08 ]. http://www. ejcancer. info/article/S0959-8049( 11) 00995-6/fulltext . [ published online ahead ofprint Decmber 26 , 2011 ].
  • 5Li A, King J,Moro A, et al. Overexpression of CXCL5 isassociated with poor survival in patients with pancreatic cancer.Am J Pathol, 2011, 178: 1340-1349.
  • 6Walz A, Burgener R,Car B,et al. Structure and neutrophil-activating properties of a novel inflammatory peptide ( ENA-78 )with homology to interleukin 8. J Exp Med, 1991,174:1355-1362.
  • 7Okabe H, Beppu T, Ueda M, et al. Identification of CXCL5/ENA-78 as a factor involved in the interaction betweencholangiocarcinoma cells and cancer-associated fibroblasts [ J/OL]. Int J Cancer, 2012 [ 2012-04-08 ]. http ://onlinelibrary.wiley. com/doi/10. 1002/ijc. 27496/full [ pubilished online aheadof print March 27,2012].
  • 8Speetjens FM, Kuppen PJ, Sandel MH, et al. Disruptedexpression of CXCL5 in colorectal cancer is associated with rapidtumor formation in rats and poor prognosis in patients. Clin CancerRes, 2008, 14:2276-2284.
  • 9Kuo PL, Chen YH, Chen TC,et al. CXCL5/ENA78 increasedcell migration and epithelial-to-mesenchymal transition of honnone-independent prostate cancer by early growth response-l/snailsignaling pathway. J Cell Physiol, 2011, 226: 1224-1231.
  • 10王琪,张玮,黎丹戎,李力.两种卵巢恶性肿瘤潜在血清标记物的纯化鉴定及临床验证[J].中华医学杂志,2008,88(15):1012-1016. 被引量:10

共引文献28

同被引文献92

引证文献21

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部